NCT07626203

Brief Summary

Venous leg ulcers are severe manifestations of chronic venous insufficiency and account for a large proportion of lower limb ulcers. They typically occur below the knee, persist for more than six weeks, and are associated with significant impairment in quality of life and substantial socioeconomic burden. A major clinical challenge is their high recurrence rate, which can reach 50-70% within six months, making treatment resource-intensive and requiring multidisciplinary care. Therapeutic ultrasound and phonophoresis have been proposed to enhance wound healing by promoting tissue repair and improving transdermal drug delivery, including hyaluronic acid, which supports extracellular matrix restoration and wound healing. However, despite the theoretical advantages of combining ultrasound with hyaluronic acid, robust clinical evidence for its effectiveness in venous leg ulcers remains limited. The study aimed to assess the effect of ultrasound-enhanced hyaluronic acid delivery on venous ulcer healing compared to ultrasound followed by topical application of hyaluronic acid.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2025

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2025

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
Last Updated

June 4, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

May 31, 2026

Last Update Submit

May 31, 2026

Conditions

Keywords

hyaluronic acidultrasoundphonophoresisvenous ulcer

Outcome Measures

Primary Outcomes (1)

  • Percentage Wound Area Reduction (PWAR)

    It is calculated as: \[(baseline wound area - post-treatment wound area) ÷ baseline wound area\] × 100. Digital wound measurements were obtained at baseline and at week four using the validated imitoMeasure smartphone application (imito AG, Zurich, Switzerland). Standardized image acquisition procedures were followed, with the smartphone camera positioned 20-30 cm from the wound and maintained parallel to the wound surface. A calibration marker (QR code) was placed adjacent to the wound on the same plane before image capture, and a photo was taken once the app recognized the QR code. The operator delineated the wound borders on the photo using their finger then the app generated measurements of area, width, length, and circumference.

    After 3 sessions per week for 4 weeks

Secondary Outcomes (1)

  • Rate of Healing

    After 3 sessions per week for 4 weeks

Study Arms (2)

Study Group A

EXPERIMENTAL

This group included 32 patients with venous ulcers who received combined treatment of topical hyaluronic acid gel and therapeutic ultrasound therapy, three sessions weekly for four weeks, in addition to the traditional physical therapy management including compression therapy and active ankle exercises.

Other: Phonophoresis group (A)

Study Group B

EXPERIMENTAL

This group included 32 patients with venous ulcers who received ultrasound first then followed by topical hyaluronic acid, three sessions weekly for four weeks in addition to the traditional physical therapy management including compression therapy and active ankle exercises.

Other: Ultrasound-preceded gel (hyaluronic acid gel) group (B):

Interventions

For Study Group (A): A layer of 0.2% topical hyaluronic acid gel was applied to cover and fill the wound cavity . A sterile glove filled with ultrasound gel was, then secured to the wound with surgical plaster, and ultrasound therapy was applied concurrently. The ultrasound was delivered for 1 minute per 1 cm² of the wound. The parameters used were 0.5 W/cm², low intensity, 1 MHz frequency, and pulsed mode with a 20% duty cycle, adjusted based on the ulcer size. The gel was removed, and the wound was dried and cleaned with saline and the US head with alcohol after each session. The treatment period lasted 4 weeks, with three sessions per week.

Study Group A

Pulsed TUS was applied to the wound area at identical parameters to Group A (0.5 W/cm², 1 MHz, 20% duty cycle, one minute per cm²). Immediately following the TUS session, 0.2% HA gel was applied topically to the wound surface. Standard wound care was delivered as described for Group A. Treatment frequency and duration were identical to Group A.

Study Group B

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both genders whose ages were between 30 - 70 years.
  • Patients with active venous ulcers (C6) according to CEAP (Clinical manifestations- Etiology- Anatomic distribution-Pathophysiology) classification.
  • clinically proved to be non-infected venous ulcers.
  • Patients receive the traditional physical therapy management for venous ulcers which includes compression therapy and active exercise plus frequent dressing change.
  • Patients suffering from recurrent or failed to heal venous ulcers.

You may not qualify if:

  • Individuals who were confined to bed with life-threatening conditions that could interfere with the study's objectives, such as myocardial infarction, renal failure or autoimmune diseases.
  • Patients who had hyaluronic acid hypersensitivity.
  • Presence of skin disorders or conditions that considered contraindicated for therapeutic US (e.g., cellulitis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient Clinics of Faculty of Physical Therapy ,Cairo University.

Giza, Egypt

Location

Related Publications (5)

  • https://www.mdpi.com/2077-0383/11/3/537

    BACKGROUND
  • https://www.mdpi.com/2073-4409/11/15/2439

    BACKGROUND
  • Alkahtani SA, Kunwar PS, Jalilifar M, Rashidi S, Yadollahpour A. Ultrasound-based Techniques as Alternative Treatments for Chronic Wounds: A Comprehensive Review of Clinical Applications. Cureus. 2017 Dec 15;9(12):e1952. doi: 10.7759/cureus.1952.

    PMID: 29487767BACKGROUND
  • Biagioni RB, Carvalho BV, Manzioni R, Matielo MF, Brochado Neto FC, Sacilotto R. Smartphone application for wound area measurement in clinical practice. J Vasc Surg Cases Innov Tech. 2021 Feb 26;7(2):258-261. doi: 10.1016/j.jvscit.2021.02.008. eCollection 2021 Jun.

    PMID: 33997567BACKGROUND
  • Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment. J Clin Med. 2020 Dec 24;10(1):29. doi: 10.3390/jcm10010029.

    PMID: 33374372BACKGROUND

MeSH Terms

Conditions

Varicose Ulcer

Interventions

Population Groups

Condition Hierarchy (Ancestors)

Varicose VeinsVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

DemographyPopulation Characteristics

Study Officials

  • HESHAM GALAL MAHRAN, Professor of PT

    Faculty of Physical Therapy, department of physical therapy for surgery, Cairo University, Egypt

    STUDY DIRECTOR
  • SHAIMAA MOHAMED ELSAYEH, Ass. Prof. of PT

    Faculty of Physical Therapy, department of physical therapy for surgery, Cairo University, Egypt

    STUDY DIRECTOR
  • WALIED MOHAMED KHEREBA, Prof. vascular surgery

    Faculty of medicine, department of vascular and endovascular surgery, AL-Azhar University New Damietta, Egypt

    STUDY DIRECTOR
  • Rasha S Farag, MSc

    Damietta Directorate for Health Affairs

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master of Physical Therapy for Surgery, Cairo University, Egypt

Study Record Dates

First Submitted

May 31, 2026

First Posted

June 4, 2026

Study Start

December 12, 2024

Primary Completion

February 20, 2025

Study Completion

February 26, 2025

Last Updated

June 4, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared due to privacy and confidentiality considerations, in accordance with institutional and ethical committee regulations governing patient data protection.

Locations